Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Exai Bio
Exai Bio is a pioneering company in the field of liquid biopsy, utilizing a next-generation RNA-based platform combined with artificial intelligence to provide actionable insights into cancer…
Exai Bio
Exai Bio is a pioneering company in the field of liquid biopsy, utilizing a next-generation RNA-based platform combined with artificial intelligence to provide actionable insights into cancer…
TL;DR
Founded: 2021
Headquarters: Palo Alto, California
Technology: RNA-based liquid biopsy (oncRNA) + AI
Notable funding: $67.5M Series A (Dec 2021)
Employee count: 23
Company Overview
Problem Domain
Early cancer detection and characterization using liquid biopsy diagnostics.
Founded
2021
Industry
Biotechnology
Funding Track Record
$67.5M
Company announcement and database listings report a $67.5M Series A in Dec 2021.
$71.5M
Dealroom lists an Early VC entry for Oct 2022.
Investor Signal
“Casdin Capital; Section 32 (S32); Two Sigma Ventures”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,300+
New This Week